Ocugen Inc (OCGN) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti

Ocugen Inc (OCGN) brendining ramzi va logotipi

Ocugen, Inc. (OCGN) daromadlar o'sishini ta'minlash uchun global hamkorlar orqali komponentlar logistikasini optimallashtirgan holda ilg'or biologik vositalarni ishlab chiqadi. FDA ning qat'iy tartibga soluvchi qoidalari va oftalmologik platformalar uchun patent himoyasi bozorga kirish uchun yuqori to'siqni ta'minlaydi. GURU.Markets platformasidagi -4.30 indikatori bilan narxlar dinamikasida aks etgan bozor holati, daromadlari infeksiyalar va retinal degeneratsiyani davolash terapiyalarining davlat xaridlalariga bog'liq bo'lgan kompaniyaning salohiyatini tasdiqlaydi.

OCGN Ocugen Inc: Narxning foydaga nisbati 04.07.2022 - 16.11.2026 oraligʻida

ocugen.com (OCGN) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Ocugen OCGN
Ocugen, Inc. yetakchi tovari

Investorlar barqaror aktivlarni qidirmoqdalar va biznesning bozor qiymatini uning daromadlariga nisbatan baholash uchun koeffitsientlardan foydalanmoqdalar. P/E koeffitsiyenti joriy aksiya narxi va aksiya uchun foyda o'rtasidagi bog'liqlikni o'lchab, investitsiyaning qoplanish muddatini aniqlaydi. Gen terapiyasi hozirda sinov bosqichida bo'lgan Ocugen, Inc. (OCGN) uchun ushbu hisob-kitob ko'rlikni davolashdagi kelajakdagi yutuqlarga bo'lgan bozor kutganlarini aks ettiradi. Ocugen, Inc. (OCGN) ning fundamental P/E koeffitsiyentini tahlil qilish orqali uning uzoq muddatli hayot sikli potensialiga to'langan premiumning miqdorini baholash mumkin.

Muhim raqobatchilar

tempus.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Isis Pharmaceuticals|P/E multiplikatori RGEN (repligen.com)|Bozor narxining sof foydaga nisbati RNA (Avidity Biosciences, Inc.)|CRSP - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati WGS (GeneDx)|RARE: P/E multiplikatori|Beam Therapeutics Corp - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti SRPT|twistbioscience.com (TWST) - Biznesning o‘zini qoplash muddati|P/E multiplikatori TXG|NTLA (Intellia) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Stoke STOK|BioLife (BLFS) - Kapitalizatsiyaning foydaga nisbati|wavelifesciences.com - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati MAZE|SION: P/E multiplikatori|PRME - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti TSHA|QURE - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori MGTX|Biznesning o‘zini qoplash muddati regenxbio.com|P/E multiplikatori SLDB (Solid Biosciences Inc)|Pacific Biosciences of California, Inc. (PACB) - Kapitalizatsiyaning foydaga nisbati|BNTC - Narxning foydaga nisbati|Design Pharma - Bozor narxining sof foydaga nisbati|RCKT (Rocket Pharmaceuticals Inc) - Narx-foyda koeffitsiyenti|4D Molecular Therapeutics (FDMT) - P/E multiplikatori|Narxning foydaga nisbati Lexeo Therapeutics, Inc.|Kapitalizatsiyaning foydaga nisbati Korro Bio, Inc. KRRO|P/E multiplikatori EDIT|Biznesning o‘zini qoplash muddati Silence Therapeutics Corp|Narxning foydaga nisbati proqr.com PRQR|CDXS - Narx-foyda koeffitsiyenti|SGMO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Nautilus Biotechnology, Inc. (NAUT)|MGX: P/E multiplikatori|Narx-foyda multiplikatori DTIL|GBIO (Generation Bio) - P/E multiplikatori|Narx-foyda multiplikatori BOLD (boundlessbio.com)|Narx-foyda koeffitsiyenti XCUR (exicuretx.com)|Celsion Corporation - Narx-foyda multiplikatori|P/E multiplikatori PHIO (phiopharma.com)|P/E multiplikatori Mustang Bio, Inc. MBIO|RNAZ: Narx-foyda koeffitsiyenti|BNGO (Bionano Genomics) - Narx-foyda multiplikatori|APDN: P/E multiplikatori|bluebird bio (BLUE) - P/E multiplikatori|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd.|Kapitalizatsiyaning foydaga nisbati Omega OMGA|P/E multiplikatori OMIC|RGLS - Kapitalizatsiyaning foydaga nisbati|Syros Pharmaceuticals, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Codex DNA (TBIO)|TCON - Narxning foydaga nisbati|UBX: Narxning foydaga nisbati